Context Therapeutics Inc.

CNTX · Nasdaq · SIC 2834: Pharmaceutical Preparations
84
SEC Filings

Business Summary

Overview We are a clinical-stage biopharmaceutical company advancing T cell engaging (TCE) bispecific antibodies (bsAb) for solid tumors. Our goal is to build an innovative portfolio of TCE bispecific therapeutics, including CTIM-76, a Claudin 6 (CLDN6) x CD3 TCE, CT-95, a Mesothelin (MSLN) x CD3 TCE, and CT-202, a Nectin cell adhesion protein 4 (Nectin-4) x CD3 TCE. Our pipeline is shown below: CTIM-76 is a CLDN6 x CD3 TCE that is intended to redirect T-cell-mediated lysis toward malignant cell...

Next Earnings

Q2 FY2026 — expected 2026-09-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCNTXdiscussed_in_filing Cybersecurity
topic_mentionCNTXdiscussed_in_filing Trusted Computing
topic_mentionCNTXdiscussed_in_filing Blockchain & Crypto
topic_mentionCNTXdiscussed_in_filing Capital Expenditure
topic_mentionCNTXdiscussed_in_filing Supply Chain
topic_mentionCNTXdiscussed_in_filing Regulation
topic_mentionCNTXdiscussed_in_filing Healthcare & Bio
topic_mentionCNTXdiscussed_in_filing Sovereign & Government
topic_mentionCNTXdiscussed_in_filing Cybersecurity
topic_mentionCNTXdiscussed_in_filing Trusted Computing
topic_mentionCNTXdiscussed_in_filing Blockchain & Crypto
topic_mentionCNTXdiscussed_in_filing Capital Expenditure
topic_mentionCNTXdiscussed_in_filing Supply Chain
topic_mentionCNTXdiscussed_in_filing Regulation
topic_mentionCNTXdiscussed_in_filing Healthcare & Bio
topic_mentionCNTXdiscussed_in_filing Sovereign & Government
topic_mentionCNTXdiscussed_in_filing Cybersecurity
topic_mentionCNTXdiscussed_in_filing Trusted Computing
topic_mentionCNTXdiscussed_in_filing Blockchain & Crypto
topic_mentionCNTXdiscussed_in_filing Capital Expenditure

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-232025-12-310001628280-26-020498EDGAR61K words
2025-03-202024-12-310001842952-25-000028EDGAR—
2024-03-212023-12-310001842952-24-000011EDGAR—
2023-03-222022-12-310001842952-23-000041EDGAR—
2022-03-232021-12-310001842952-22-000029EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001628280-25-049533EDGAR19K words
2025-08-062025-06-300001842952-25-000081EDGAR—
2025-05-072025-03-310001842952-25-000048EDGAR—
2024-11-062024-09-300001842952-24-000085EDGAR—
2024-08-072024-06-300001842952-24-000065EDGAR—
2024-05-082024-03-310001842952-24-000035EDGAR—
2023-11-092023-09-300001842952-23-000085EDGAR—
2023-08-092023-06-300001842952-23-000078EDGAR—
2023-05-102023-03-310001842952-23-000054EDGAR—
2022-11-092022-09-300001842952-22-000096EDGAR—
2022-08-112022-06-300001842952-22-000071EDGAR—
2022-05-112022-03-310001842952-22-000041EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-020001628280-26-022931EDGAR1K words
2026-03-230001628280-26-020517EDGAR—
2026-03-130001628280-26-017691EDGAR—
2026-02-270001628280-26-012813EDGAR—
2026-01-080001628280-26-001275EDGAR—
2025-11-050001628280-25-049604EDGAR—
2025-10-240001628280-25-046258EDGAR—
2025-10-200001628280-25-045513EDGAR—
2025-09-020001842952-25-000085EDGAR—
2025-06-120001842952-25-000072EDGAR—

84 total filings indexed. 57 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001842952
TickerCNTX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 9ffd9a99122c921dd6692dfb97a4f5889b06f957baa87225037a88a42652074d
parent: af7ebb2a339d61c57ca9e779a118bf8a87bd062579e6f490c6aa13fdc67270c8
content hash: dc53d6dc115933fec205071a674271c3fe817e84771c1826933a5bbd62b72a8e
signed: 2026-04-13T04:44:25.273Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf